AI-Powered News AnalysisCompare coverage across the political spectrum
Back to Dashboard
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters

Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters

Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters

August 14, 2026 at 10:41 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

All Coverage

Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOc2dJTF9ubExhMWNSWC05bUl3dXRpOFBXWG55cHZCRkQtUVczS1ZWTnM2dXpQeTdHdXV4MVJoLURBZEl5WHBoQ3NQT1YzTmVUeVlONXJ1N1dBNE5hTTdwNERqMnR4SlcwQ2RNYk9vQndlU3Y2ZEl0X0xBVUs3MDNJdnhwZk1KcThfNGFCbkp0VG0xQWFoOGhEbDlzUXVqSzRsaXB5d0N6bkpXemNaalhLeV81TzRNY1R2OWU2aUNQenppbGppMV9EVEdpSU9nMFF5WExMcQ?oc=5" target="_blank">Capricor shares skyrocket as FDA agrees to review new Duchenne drug data</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%